Advent Capital Management »

Apellis Pharmaceuticals shares owned by Advent Capital Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Advent Capital Management from 13F filings

Historical chart of Advent Capital Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Advent Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Advent Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $452k 18k 25.12

More positions owned by Advent Capital Management

Spdr S&p 500 Etf Call Option (SPY)
Bank Of America Corp Conv Pfd (BAC.PL)
Wells Fargo & Company Conv Pfd (WFC.PL)
Uber Technologies Conv (Principal)
Global Payments Conv (Principal)
Ventas Realty Conv (Principal)
Meritage Homes Corp Conv (Principal)
Kkr & Co Conv Pfd (KKR.PD)
Nextera Energy Conv Pfd (NEE.PS)
Apollo Global Management Conv Pfd (APO.PA)
Cms Energy Corp Conv (Principal)
Nextera Energy Capital Conv (Principal)
Tyler Technologies Conv (Principal)
Ppl Capital Funding Conv (Principal)
Duke Energy Corp Conv (Principal)

View all positions for Advent Capital Management

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Wellington Management Company
Deep Track Capital
Rtw Investments
BlackRock
State Street Corporation
AQR Capital Management
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors
Geode Capital Management
Jennison Associates

View all funds holding Apellis Pharmaceuticals